发明名称 THERAPEUTIC AGENT FOR CEREBRAL NERVE DISORDER
摘要 PURPOSE:To obtain a therapeutic agent for cerebral nerve disorders, containing a hepatocyte growth factor as the active component and capable of promoting survival of cerebral nerve cells and regenerating and repairing the injured brain. CONSTITUTION:HGF (Hepatocyte-Growth Factor) is contained as the active component. This medicine is useful for therapy and prevention of Alzheimer's disease in which atrophy or degenerative deciduation of neurocyte is observed, Alzheimer type senile dementia, amyotrophic lateral sclerosis, nerve regeneration diseases such as Parkinson disease, cerebral apoplexy, cerebral embolism, cerebral trauma, etc. As the dosage form, liquid, solid formulation, capsule, etc., can be used and the dosage is 0.01 to 100mg/day on HGF base.
申请公布号 JPH0789869(A) 申请公布日期 1995.04.04
申请号 JP19930254859 申请日期 1993.09.17
申请人 NAKAMURA TOSHIICHI;SUMITOMO PHARMACEUT CO LTD 发明人 NAKAMURA TOSHIICHI
分类号 A61K38/22;A61K38/00;A61K38/18;A61P25/00;A61P25/28;C07K14/475;(IPC1-7):A61K38/22 主分类号 A61K38/22
代理机构 代理人
主权项
地址